GM

Gembali Mallikarjuna Rao

Active Director Director DIN 00109396
DIN 00109396 First appointment Jan 2023 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Gembali Mallikarjuna Rao

Data last updated:

Gembali Mallikarjuna Rao is a Director at Krishna Pharma Private Limited (since 2023). The company operates in Chemicals.

DIN 00109396
Primary Designation Director
Industry Chemicals
First Appointment 20 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Krishna Pharma Private Limited U24299TG2023PTC170591
Director20 Jan 20232023Active

Board colleagues of Gembali Mallikarjuna Rao

NameDINCompanyDesignation
Gembali Lakshmi00109395Krishna Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Krishna Pharma Private Limited
Premium access

Shareholding and investment profile for Gembali Mallikarjuna Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gembali Mallikarjuna Rao

Gembali Mallikarjuna Rao currently holds 1 directorship: Krishna Pharma Private Limited (Director, since 20 Jan 2023).

Gembali Mallikarjuna Rao was first appointed on 20 Jan 2023 as Director at Krishna Pharma Private Limited.

The current boards of Gembali Mallikarjuna Rao's companies include Gembali Lakshmi (Krishna Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available